Audax Private Equity Acquires Avantor's Clinical Services Business, Rebrands it as Resonant Clinical Solutions
October 18, 2024
Audax Private Equity has completed the acquisition of Avantor, Inc.'s Clinical Services business and rebranded the business as Resonant Clinical Solutions. The divestiture—reported at roughly $650 million—transfers a global clinical trial services platform (EPL Archives, MESM, Therapak) to Audax, which plans to invest in organic and inorganic growth to expand capabilities for pharmaceutical, biotech, CRO, and diagnostic customers.
- Buyers
- Audax Private Equity
- Targets
- Clinical Services business of Avantor, Inc. (rebranded as Resonant Clinical Solutions)
- Sellers
- Avantor, Inc.
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Catalyst Clinical Research Acquires Aptus Clinical
May 4, 2022
Healthcare Services
Catalyst Clinical Research, a portfolio company of NovaQuest Capital Management, has acquired U.K.-based Aptus Clinical to accelerate Catalyst's European expansion and broaden its oncology and early-phase clinical services. The deal creates a multi-region CRO operating across North America and Europe, increases Catalyst's patient reach by nearly 600 and lifts combined headcount to more than 800.
-
Audax Private Equity Acquires Majority Stake in Lanter Delivery Systems
February 7, 2025
Logistics & Distribution
Audax Private Equity has acquired a majority stake in Lanter Delivery Systems from Equity Group Investments. Lanter, based outside St. Louis, operates a nationwide overnight, unattended delivery network serving automotive, agriculture, heavy-truck and industrial customers; Audax plans to invest in the network and technology to accelerate growth and expand end markets.
-
Novo Holdings Acquires Altasciences from Audax Private Equity
February 22, 2021
Healthcare Services
Novo Holdings has agreed to acquire Altasciences, a Laval, Canada–headquartered contract research and CDMO services provider, from Audax Private Equity. Altasciences— which operates six facilities across the U.S. and Canada and employs over 1,300 people—will remain led by CEO Chris Perkin and is expected to continue expanding domestically and internationally under Novo Holdings' ownership.
-
ELIQUENT Life Sciences Acquires Azzur Consulting
May 7, 2025
Healthcare Services
ELIQUENT Life Sciences, a GHO Capital‑backed global regulatory, quality, and safety consulting firm, has acquired Azzur Consulting to strengthen its validation engineering, CQV, and quality/compliance capabilities. The Azzur team will integrate into ELIQUENT's global delivery organization to expand technical delivery across North America, Europe, Japan and other markets.
-
Avantor Acquires Ritter GmbH and Its Affiliates
June 10, 2021
Medical Devices
Avantor, Inc. completed its acquisition of Ritter GmbH and its affiliates, a Germany-based manufacturer of high-precision robotic and liquid-handling consumables, in an all-cash transaction announced in 2021. The deal (upfront equity purchase price approx. €890 million plus potential earnouts) expands Avantor's proprietary offering for diagnostic and drug-discovery workflows and is expected to be immediately accretive to adjusted EPS while enhancing revenue growth and margins.
-
Audax Private Equity Recapitalizes Corrona, LLC
December 19, 2019
Healthcare Services
Audax Private Equity has recapitalized Corrona, LLC in partnership with Corrona's management team; terms were not disclosed. Great Point Partners exited its investment as Audax and management position Corrona to expand its real-world evidence registries, data capabilities and pursue further growth.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.